Bone

InventHelp Inventor Develops Wearable Wellness Monitor (LCC-3748)

Retrieved on: 
Monday, June 4, 2018
Lancaster, Pennsylvania, Bone, Geography of Pennsylvania

Upon undergoing multiple tests, it was discovered she was also suffering from stage four bone cancer.

Key Points: 
  • Upon undergoing multiple tests, it was discovered she was also suffering from stage four bone cancer.
  • As a result she developed the CareBit, CareBit Plus to monitor the care and track the activity of a loved one in a hospital, rehabilitation facility or nursing home.
  • The original design was submitted to the Lancaster office of InventHelp.
  • 17-LCC-3748, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext.

A Study Confirms - Bindex ® Point-of-care Technology is Extremely Cost-effective in Osteoporosis Management

Retrieved on: 
Tuesday, May 29, 2018
Anatomy, Osteopathies, Aging-associated diseases, Endocrine diseases, Osteoporosis, RTT, Bone

A new study* published in ClinicoEconomics and Outcomes Research reveals the immense cost-effectiveness and cost savings of Bindex point-of-care device in osteoporosis management pathway.

Key Points: 
  • A new study* published in ClinicoEconomics and Outcomes Research reveals the immense cost-effectiveness and cost savings of Bindex point-of-care device in osteoporosis management pathway.
  • In this parallel study, Bindex was implemented in the traditional management pathway and the new pathway was compared to the traditional one.
  • With Bindex, we can notably improve the access for the highly needed osteoporosis examinations and yet save both time and money," says Bone Index's CEO, Dr. Ossi Riekkinen.
  • Bindex detects osteoporosis with 90% sensitivity and specificity and will significantly help physicians with diagnosis.

Cerapedics Announces Presentation of Results from the IVANOS Study of i-FACTOR™ Peptide Enhanced Bone Graft in Uninstrumented Lumbar Posterolateral Spine Surgery

Retrieved on: 
Monday, May 21, 2018
Medicine, Clinical medicine, Transplantation medicine, Surgery, Bone grafting, Bone, Graft, Allotransplantation

WESTMINSTER, Colo., May 21, 2018 /PRNewswire/ --Cerapedics, a privately-held orthobiologics company, today announced results from the IVANOS study evaluating i-FACTOR Peptide Enhanced Bone Graft in lumbar posterolateral spine surgery.

Key Points: 
  • WESTMINSTER, Colo., May 21, 2018 /PRNewswire/ --Cerapedics, a privately-held orthobiologics company, today announced results from the IVANOS study evaluating i-FACTOR Peptide Enhanced Bone Graft in lumbar posterolateral spine surgery.
  • i-FACTOR Peptide Enhanced Bone Graft is based on proprietary synthetic small peptide (P-15) technology developed by Cerapedics to support bone growth through cell attraction, attachment and activation.
  • i-FACTOR Peptide Enhanced Bone Graft is the only biologic bone graft in orthopedics that incorporates a small peptide as an attachment factor to stimulate the natural bone healing process.
  • i-FACTOR Peptide Enhanced Bone Graft must be used inside an allograft bone ring and with supplemental anterior plate fixation.

Break Free from Osteoporosis for May's National Osteoporosis Month: What You Need to Know About Your Bone Health at Every Age

Retrieved on: 
Friday, April 27, 2018
Anatomy, Osteopathies, Bone fractures, Osteoporosis, RTT, Bone, Medication-associated osteonecrosis of the jaw, World Osteoporosis Day, National Osteoporosis Society

NOF's call to action to Break Free from Osteoporosis is an awareness and educational initiative to help the public learn more about building bone strength and preventing fractures.

Key Points: 
  • NOF's call to action to Break Free from Osteoporosis is an awareness and educational initiative to help the public learn more about building bone strength and preventing fractures.
  • "We're encouraging everyone to get active, follow a bone healthy diet and learn the facts about osteoporosis treatment to prevent fractures and the pain and suffering that results."
  • For National Osteoporosis Month, NOF is continuing its Jumping Jack Challenge.
  • Visit NOF.org for these free, downloadable resources you can pass along and share to help everyone Break Free from Osteoporosis this May for National Osteoporosis Month.

Marine Collagen Market - Global Forecast to 2023

Retrieved on: 
Friday, April 27, 2018
Anatomy, Skeletal system, Structural proteins, Soft tissue, Collagen, Tendon, Bone, Hydrolyzed collagen, Alpha collagen

The "Marine Collagen Market by Type (Type I, Type II, Type III), Source (Skin, Scales, & Muscles, Bones & Tendons), Animal (Fish & Other Animals), Application (Nutraceuticals, Cosmetics, Medical), and Region - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Marine Collagen Market by Type (Type I, Type II, Type III), Source (Skin, Scales, & Muscles, Bones & Tendons), Animal (Fish & Other Animals), Application (Nutraceuticals, Cosmetics, Medical), and Region - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.
  • The global market for marine collagen has grown exponentially in the last few years.
  • The marine collagen market, based on type, is segmented into type I, type III, and others.
  • The marine collagen market, based on source, is segmented into skin, scales, and muscles, bones & tendons, and others.

Global Bone Wax Market to Reach US$ 84.2 Mn in 2026; Innovations in Bone Wax Products and Usage as a Drug Carrier for Medications to Fuel Market Growth

Retrieved on: 
Tuesday, May 8, 2018
Anatomy, Waxes, Biomaterials, Bone wax, Beeswax, Bone, Antihemorrhagic

The bone wax market in Latin America is likely to witness sluggish growth from 2018 to 2026.

Key Points: 
  • The bone wax market in Latin America is likely to witness sluggish growth from 2018 to 2026.
  • Bone wax product offers hemostatic property which is used to physically block bleeding and the bone.
  • Bone wax products include white beeswax as the major component which is formulated with around 70% beeswax and around 30% of softening agents.
  • Request A Sample Of Bone Wax Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_...
    The global bone wax market is fragmented, with presence of several small scale and large scale companies.

HSS Researchers Launch Study to Measure Bone Effects of New Rheumatologic Agent

Retrieved on: 
Monday, May 7, 2018
Anatomy, Osteopathies, Osteoporosis, RTT, International Osteoporosis Foundation, Bone, Medication-associated osteonecrosis of the jaw, National Osteoporosis Society

Despite the overactive growth of bone, people with SpA often suffer from osteoporosis, a condition marked by fragile skeletons vulnerable to fracture.

Key Points: 
  • Despite the overactive growth of bone, people with SpA often suffer from osteoporosis, a condition marked by fragile skeletons vulnerable to fracture.
  • Osteoporosis and low bone mass affect an estimated 44 million men and women in the United States, according to the International Osteoporosis Foundation.
  • The study, "The Effects of Secukinumab on Bone Health and Metabolism," is now enrolling patients.
  • The HSS Education Institute provides continuing medical curriculum to more than 15,000 subscribing musculoskeletal healthcare professionals in 110 countries.